Traffic Roots Pixel
 

CBD

GPR55: the third cannabinoid receptor

Posted on June 18th, 2018 by Bill Weinberg and tagged , , , , , , .

THCFor a generation now, science has known of two cannabinoid receptors—specialized protein molecules that interact with the active compounds in the cannabis plant for the human body. These are CB1 and CB2, both discovered in the early '90s. Now there is growing awareness of a third such receptor that was identified in 2007. This receptor, GPR55, may be key to understanding a wide spectrum of therapeutic applications for cannabinoids—and especially the non-psychoactive cannabidiol, or CBD.

New Zealand moves toward medical marijuana —and legalization

Posted on June 9th, 2018 by Bill Weinberg and tagged , , , , , , , .

OceaniaThe government of New Zealand has announced that it plans to hold a referendum on cannabis legalization, possibly as early as next year. A medical marijuana bill is already pending in the country's parliament. But it has taken generations of activist effort by Kiwis to bring Aotearoa (by the country's indigenous Maori name) to this point. Cannabis Now speaks with some of the leaders who made it happen.

Corporate patent scramble for CBD applications

Posted on May 31st, 2018 by Global Ganja Report and tagged , , , , , , , , , , .

cannabisSomething of a corporate scramble is underway to secure patents for the various curative properties of CBD, and associated products and procedures. Pharmaceutical firms see a windfall, but some activists raise concerns about the creeping privatization of a cannabinoid that should belong to the genetic and intellectual commons of the human race. How realistic are fears about the imminent arrival of "corporate cannabis"?

Cannabis enterprises enter stock exchange through reverse mergers

Posted on May 30th, 2018 by Global Ganja Report and tagged , , , , , , , , , .

Shadow WatchWith US stock exchanges still almost entirely closed to cannabis businesses, the stateside industry is increasingly seeking access to the Canadian exchanges in order to secure investment. Taking over publicly traded Canadian firms through reverse mergers has emerged as the critical tactic in this endeavor.

Marijuana and Mother Courage

Posted on May 9th, 2018 by Global Ganja Report and tagged , , , , , , , , , .

medical marijuanaAround the world, mothers are on the frontlines of demanding legal access to cannabis products for their children who suffer from epilepsy and other ailments. Often, these courageous moms have risked their freedom to provide medicine for their offspring. Sometimes they have actually shamed the authorities into changing the law—but still face the prospect of prison time.

Appeals court upholds CBD's status as controlled substance

Posted on May 7th, 2018 by Global Ganja Report and tagged , , , , , , , , , , , .

cannabisA federal appeals court has turned down a challenge by the cannabis industry to the DEA's official finding that CBD is a controlled substance. But questions about whether CBD should be treated as a controlled substance remain pending at the state level.

Scientists examine cannabinoid impact on bone density

Posted on April 25th, 2018 by Global Ganja Report and tagged , , , .

THCA recent study about the impact of cannabinoids on bone density is raising concerns about possible ill effects on longterm heavy marijuana smokers. Earlier studies, however, showed potential for certain cannabinoids in treating bone fractures. The relationship between cannabis and bone-building function may be more complicated than recent media reports suggest.

Utah: race between medical marijuana initiative and restrictive house bill

Posted on April 24th, 2018 by Global Ganja Report and tagged , , , , , .

UtahReports indicate that promoters of a popular initiative for a medical marijuana law in Utah have won enough signatures to get their proposal before the state's voters in November. A far more restrictive law allowing use of CBD preparations is meanwhile before the state house. The ballot initiative would make the legislation basically irrelevant—but faces stiff opposition.

Who's new

  • Baba Israel
  • Karr Young
  • John Veit
  • YosephLeib
  • Peter Gorman